GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Peijia Medical Ltd (HKSE:09996) » Definitions » EV-to-EBIT

Peijia Medical (HKSE:09996) EV-to-EBIT : -3.92 (As of May. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Peijia Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Peijia Medical's Enterprise Value is HK$1,677.0 Mil. Peijia Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil. Therefore, Peijia Medical's EV-to-EBIT for today is -3.92.

The historical rank and industry rank for Peijia Medical's EV-to-EBIT or its related term are showing as below:

HKSE:09996' s EV-to-EBIT Range Over the Past 10 Years
Min: -35.36   Med: -4.86   Max: -1.27
Current: -3.92

During the past 6 years, the highest EV-to-EBIT of Peijia Medical was -1.27. The lowest was -35.36. And the median was -4.86.

HKSE:09996's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs HKSE:09996: -3.92

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Peijia Medical's Enterprise Value for the quarter that ended in Jun. 2023 was HK$3,193.3 Mil. Peijia Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil. Peijia Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -13.40%.


Peijia Medical EV-to-EBIT Historical Data

The historical data trend for Peijia Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peijia Medical EV-to-EBIT Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial - -6.04 -8.63 -10.47 -9.88

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -8.63 - -10.47 - -

Competitive Comparison of Peijia Medical's EV-to-EBIT

For the Medical Devices subindustry, Peijia Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peijia Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Peijia Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Peijia Medical's EV-to-EBIT falls into.



Peijia Medical EV-to-EBIT Calculation

Peijia Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1677.005/-428.021
=-3.92

Peijia Medical's current Enterprise Value is HK$1,677.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peijia Medical  (HKSE:09996) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Peijia Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-428.021/3193.33676
=-13.40 %

Peijia Medical's Enterprise Value for the quarter that ended in Jun. 2023 was HK$3,193.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Peijia Medical's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-428.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Peijia Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Peijia Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Peijia Medical (HKSE:09996) Business Description

Traded in Other Exchanges
N/A
Address
8 Zhongtian Street, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.
Executives
Jinnius Drive Trust 2103 Interests held jointly with another person
Xinyue International Limited 2103 Interests held jointly with another person
Ye Hong 2103 Interests held jointly with another person
Zhang Ping Ye 2103 Interests held jointly with another person
Zhang Yi 2301 Trustee
Hanlindale Trust 2103 Interests held jointly with another person
Hillhouse Investment Management, Ltd. 2102 Investment manager
Hh Imv Holdings, L.p. 2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p. 2201 Interest of corporation controlled by you
Hh Sum-xxiv Holdings Limited 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Lav Asset Management (hong Kong) Limited 2102 Investment manager
Shi Yi 2201 Interest of corporation controlled by you

Peijia Medical (HKSE:09996) Headlines

No Headlines